• Dual-Network Microgels for Intervertebral Disc Degeneration

  2026-09-03

  The reference study develops an elastic, stimulus-responsive dual-network microsphere that combines miR-155 delivery, reactive oxygen species control, and inflammation modulation for intervertebral disc degeneration. Its design addresses both the hostile nucleus pulposus microenvironment and the intracellular apoptosis of nucleus pulposus cells, offering a useful framework for multifunctional regenerative biomaterials.

• WZ4003: Practical NUAK1/2 Assay Guidance

  2026-09-02

  Learn how WZ4003 (SKU B1374) can support mechanistic cell proliferation, migration, invasion, and tau-phosphorylation studies. This scenario-based guide covers assay interpretation, solvent compatibility, protocol parameters, target-engagement controls, and evidence-based product selection.

• Annexin V-Cy5 Apoptosis Kit in Microglia

  2026-09-02

  Discover how the Annexin V-Cy5 Apoptosis Kit strengthens Annexin V apoptosis detection in zebrafish microglia models. This article explains how PS exposure can distinguish genuine cell death from reversible lysosomal stress and guides complementary flow cytometry and microscopy workflows.

• Lypressin Acetate: Workflows for GPCR Research

  2026-09-01

  Lypressin acetate supports parallel investigation of V1a, V1b, and V2 receptor signaling, making it useful for antidiuretic, vasoconstriction, and vasopressor activity assays. This workflow-focused guide also explains how to evaluate its exploratory SARS-CoV-2 RdRp relevance without confusing binding evidence with validated antiviral efficacy.

• Lypressin acetate: Reliable Assay Workflows

  2026-09-01

  This scenario-based guide explains how Lypressin acetate, SKU N2888, can improve the interpretability of GPCR-linked viability, proliferation, cytotoxicity, and vasopressor experiments. It addresses peptide handling, receptor-context controls, potency normalization, cross-domain antiviral interpretation, and practical supplier selection.

• Capsazepine for TRPV1 Ion Channel Antagonism

  2026-08-31

  Capsazepine provides a practical pharmacological switch for separating TRPV1-driven nociception from broader neuronal and cancer-cell responses. This workflow-focused guide covers assay setup, concentration selection, calcium imaging, pain-model interpretation, apoptosis studies, and troubleshooting of solubility and off-target effects.

• PRMT5, Splicing, and Metabolism in MYCN Neuroblastoma

  2026-08-31

  The reference study identifies a mechanistic link between PRMT5-dependent spliceosomal control, epitranscriptomic regulation, and glutamine metabolism in MYCN-amplified neuroblastoma. Its integrated pharmacological, transcriptomic, isotope-tracing, molecular, and mouse-model analyses show that altered RNA processing can reduce GLS protein abundance and expose a metabolic vulnerability relevant to cancer metabolism research.

• 7ACC2: Monocarboxylate Transporter 1 Inhibitor

  2026-08-30

  7ACC2 is a carboxycoumarin monocarboxylate transporter 1 inhibitor that blocks MCT1-associated lactate uptake at a reported IC50 of approximately 10 nM in SiHa cells. Its reported effects on mitochondrial pyruvate transport and tumor radiosensitization make it a useful research probe for cancer metabolism research, but the available evidence does not establish clinical efficacy.

• Lypressin Acetate: Workflows for GPCR Research

  2026-08-29

  Lypressin acetate is a lysine-containing vasopressin analog for connecting V1a, V1b, and V2 receptor biology with antidiuretic, vasopressor, and emerging antiviral assays. This workflow-centered guide covers assay setup, quantitative activity interpretation, stability controls, and the limitations of extending receptor pharmacology into SARS-CoV-2 RdRp research.

• PR-619 for DUB Pathway Assays

  2026-08-28

  PR-619 is a cell-permeable, reversible deubiquitylating enzymes inhibitor for separating DUB-driven protein accumulation from direct proteasome blockade. This workflow-focused guide covers dose design, autophagy and ubiquitination assays, cancer biology research, neurodegenerative disease models, and practical troubleshooting.

• CB-839 and the Splicing–Glutamine Axis in Neuroblastoma

  2026-08-28

  PRMT5-dependent splicing can expose a glutamine-metabolic weakness in MYCN-amplified neuroblastoma. This article explains how CB-839 (Telaglenastat), a selective GLS1 inhibitor, can serve as a pharmacologic probe for testing that vulnerability while improving translational study design.

• Viral RIPK3 Degradation and Inflammation

  2026-08-27

  Liu et al. identified a family of orthopoxvirus proteins, termed viral inducers of RIPK3 degradation, that use host SCF machinery to promote RIPK3 ubiquitination and proteasomal loss. The study connects this immune-evasion mechanism to necroptosis suppression, viral replication, inflammation, and disease severity in mouse infection models.

• BACE Inhibition, Aβ, and Synaptic Transmission

  2026-08-27

  Satir et al. tested whether partial β-secretase inhibition could reduce amyloid beta secretion without disrupting neuronal function. Using primary rat cortical cultures and optical electrophysiology, they found that Aβ reduction below 50% did not impair synaptic transmission, whereas stronger inhibition reduced both Aβ secretion and synaptic activity.

• BCA Protein Assay Kit for Colitis Research

  2026-08-26

  Discover how the BCA Protein Assay Kit supports rigorous bicinchoninic acid protein quantification in DSS-colitis research. This guide connects matrix-aware protein concentration measurement with barrier biology, immunoassays, and microbiome–metabolome interpretation.

• Molidustat (BAY85-3934) in Cell Assays

  2026-08-26

  A scenario-based guide to using Molidustat (BAY85-3934), SKU B5861, in hypoxia, viability, proliferation, and cytotoxicity workflows. It connects HIF-PH biology with formulation control, assay interpretation, and practical product-selection decisions.

8082 records 1/539 page Next 12345 下5页 Last page